The method was demonstrated by researchers at the National University of Singapore, who grew 3D osteosarcoma tumors on silk scaffolds in a pressurized bioreactor. The model tumor was able to express makers that indicate blood vessel growth and respond to drugs that prevent blood vessel formation in a similar way to that of the mouse model, helping to bridge the gap between animal and laboratory testing.